tirzepatide vs semaglutide tablets caused roughly half as many patients to stop treatment because of gastrointestinal side effects as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide Tirzepatide as Compared with Semaglutide

In preclinical models, co-administration of bimagrumab or dual myostatin/activin A inhibitors with GLP-1R agonists preserves or increases muscle mass while enhancing fat loss, resulting in improved body composition and metabolic outcomes compared with GLP-1R agonist monotherapy [176]

Disclaimer: This article is for informational purposes only and does not constitute medical advice

Manish Sahni, MD, provides comprehensive, physician-led guidance to ensure that your transition onto Wegovy (semaglutide) is safe, informed, and effective

There are also some other side effects to be aware of

Its often covered by Aetna insurance and Aetna Medicare plans when its prescribed for Type 2 diabetes or cardiovascular risk, but it depends completely on the specific plan